Hem › Esophageal adenocarcinom › Illinois
Kliniska studier för Esophageal adenocarcinom i Illinois
11 studier för Esophageal adenocarcinom söker deltagare vid platser i Illinois.
Städer i Illinois
- Chicago8 studier
- Evanston6 studier
- Waukegan4 studier
- Springfield3 studier
- Joliet3 studier
- Arlington Heights3 studier
Officiell studietext (engelska)
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- Advocate Good Shepherd Hospital, Barrington
- och 37 fler
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- och 54 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT05677490Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Orchard Healthcare Research Inc.- Skokie, Skokie
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT06324357A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- Local Institution - 0379, Chicago
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT07221149Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
- Illinois Cancer Specialists, Arlington Heights
- Illinois CancerCare - Bloomington, Bloomington
- Illinois Cancer Specialists, Chicago
- och 7 fler
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07392892A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- City of Hope Cancer Center-Chicago, Zion
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07277413Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- Northwestern Memorial Hospital, Chicago
Rekryterar
Ålder 18 till 89 · Alla kön · Uppdaterad 11 sep. 2026 · NCT05753748Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Chicago
- Research Site, Niles
- Research Site, Zion
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT07431281A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Orchard Healthcare Research Inc, Skokie
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 5 aug. 2026 · NCT06330064A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Ingalls Family Care Center, Calumet City
- UChicago Medicine - River East, Chicago
- The University Of Chicago, Chicago
- och 13 fler
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 6 juli 2026 · NCT04389632Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- Northwestern University, Chicago
Rekryterar
Ålder 18 till 89 · Alla kön · Uppdaterad 1 juli 2026 · NCT05530343Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.